Androgen-induced AR reprogramming is also observed after downregulation of FoxA1, a pioneer transcription factor involved in AR targeting and frequently mutated in prostate cancer (21,23,24), although the role of FoxA1 in CRPC remains to be determined. Here, AR is linked to prostate carcinoma.